As discussed earlier, our data showed that CRP is an enhancer of MDSC generation and suppressive function and CRP can also inhibit dendritic cell function; therefore we predict that compared to wild type mice, CRPtg should have more MDSCs and more tumor burden while the inverse should be seen in CRP−/− mice. The gene discussed is CRP; the disease is neoplasm.